Source Feed: The Globe and Mail
Author: Nicole Ireland
Publication Date: November 8, 2024 - 11:14
Health Canada approves Moderna’s mRNA RSV vaccine, company says
November 8, 2024
Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.The company says it expects the RSV vaccine – called mRESVIA – to be available in early 2025. There are two other vaccines already available in Canada to protect seniors against severe illness caused by RSV: Arexvy, manufactured by GSK, and Abrysvo, made by Pfizer.
The ongoing crisis has led to a surge in homelessness across Montreal and now one artist is now drawing from his own experiences to amplify the voices that often go unheard.
November 18, 2024 - 13:47 | Matilda Cerone | Global News - Canada
The Ontario government has tabled legislation to prohibit supervised consumption sites in proximity to schools and child care centres, as well as require municipalities and local boards to seek provincial approval for new locations – following through on a plan announced in the aftermath of a fatal shooting outside a facility in Toronto.Ontario Health Minister Sylvia Jones announced in August that government’s plan would result in the closure of 10 sites, which account for nearly half of all facilities in the province. The announcement followed a review of supervised consumption...
November 18, 2024 - 13:46 | Kristy Kirkup, Laura Stone | The Globe and Mail
'We don't have a political view... We just wanted to give people who feel threatened to have a way to get out,' CEO Mikael Petterson said
November 18, 2024 - 13:35 | Kenn Oliver | National Post
Comments
Be the first to comment